South Africa concludes the sale of their Oxford-AstraZeneca vaccines to the African Union after the country stopped using these vaccines because they were found to be not highly effective against the 501.V2 variant. (News24) COVID-19 pandemic in South AfricaCOVID-19 pandemic link embed save